PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
2011.37%
Net income growth above 1.5x CSIQ's 158.41%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
17.88%
D&A growth of 17.88% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
100.00%
Deferred tax of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
50.94%
Well above CSIQ's 36.36% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
100.00%
AR growth of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-3.58%
Negative yoy inventory while CSIQ is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-100.00%
Negative yoy AP while CSIQ is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
85.91%
Growth well above CSIQ's 36.36%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-112.53%
Negative yoy while CSIQ is 126.30%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
169.34%
Operating cash flow growth similar to CSIQ's 171.37%. Walter Schloss would see parallel improvements or market conditions in cash generation.
35.17%
Some CapEx rise while CSIQ is negative at -1.91%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-112.45%
We reduce yoy invests while CSIQ stands at 4.41%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
48389.76%
Issuance growth of 48389.76% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.